Rafferty Asset Management LLC Sells 241 Shares of STERIS plc (NYSE:STE)

Rafferty Asset Management LLC cut its holdings in shares of STERIS plc (NYSE:STEFree Report) by 2.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,054 shares of the medical equipment provider’s stock after selling 241 shares during the period. Rafferty Asset Management LLC’s holdings in STERIS were worth $2,210,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the business. Greenleaf Trust grew its position in STERIS by 2.8% during the 3rd quarter. Greenleaf Trust now owns 1,888 shares of the medical equipment provider’s stock worth $414,000 after acquiring an additional 51 shares during the last quarter. Park Edge Advisors LLC boosted its position in STERIS by 1.2% in the 4th quarter. Park Edge Advisors LLC now owns 4,409 shares of the medical equipment provider’s stock valued at $969,000 after buying an additional 51 shares during the last quarter. UMB Bank n.a. boosted its position in STERIS by 7.8% in the 4th quarter. UMB Bank n.a. now owns 716 shares of the medical equipment provider’s stock valued at $157,000 after buying an additional 52 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund boosted its position in STERIS by 1.5% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 3,520 shares of the medical equipment provider’s stock valued at $774,000 after buying an additional 53 shares during the last quarter. Finally, Legacy Wealth Asset Management LLC boosted its position in STERIS by 1.5% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 3,544 shares of the medical equipment provider’s stock valued at $779,000 after buying an additional 54 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, VP Renato Tamaro sold 1,154 shares of the firm’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the sale, the vice president now owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Jacqueline B. Kosecoff sold 4,584 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $231.53, for a total transaction of $1,061,333.52. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Renato Tamaro sold 1,154 shares of STERIS stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total value of $267,312.56. Following the completion of the sale, the vice president now directly owns 6,677 shares in the company, valued at approximately $1,546,660.28. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,762 shares of company stock valued at $1,798,477. 0.95% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have commented on STE shares. Piper Sandler reiterated a “neutral” rating and issued a $225.00 price objective (up from $220.00) on shares of STERIS in a research report on Friday, May 10th. StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research report on Friday. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Friday, May 10th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, May 9th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and a consensus price target of $241.60.

Get Our Latest Analysis on STE

STERIS Stock Performance

STE stock opened at $226.85 on Monday. The business’s fifty day moving average is $216.92 and its 200-day moving average is $219.28. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49. The company has a market cap of $22.44 billion, a P/E ratio of 59.38 and a beta of 0.85. STERIS plc has a twelve month low of $195.47 and a twelve month high of $254.00.

STERIS (NYSE:STEGet Free Report) last posted its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $2.41 by $0.17. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The firm’s quarterly revenue was up 10.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.30 EPS. Equities research analysts forecast that STERIS plc will post 9.24 EPS for the current year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 0.92%. The ex-dividend date is Wednesday, June 12th. STERIS’s payout ratio is presently 54.45%.

STERIS Company Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.